-54%

est. 2Y upside i

HealthcareSeries B

Building powerful data analysis software for developing countries.

Rank

#819

Sector

Health Care Information Technology

Est. Liquidity

~5Y

Data Quality

Data: Medium

Zenysis presents a moderate upside opportunity, driven by its specialized niche in public health data analytics for governments and non-profits, and its 'Digital Public Good' recognized open-source platform.

Last updated: March 10, 2026

Bull (35%)+250%

Zenysis successfully triples its global footprint as stated by the CEO, expanding its Harmony platform to more governments and non-profits, especially in low- and middle-income countries. This strong market penetration and 'Digital Public Good' status drive revenue significantly, justifying a valuation of $210M+ by 2028, representing a 3.5x return on the current estimated valuation.

Base (45%)+50%

Zenysis continues to grow steadily within its niche, securing additional long-term contracts for its Harmony platform and strategic consulting services. While facing competition, its specialized expertise and open-source model allow it to maintain market share, leading to a valuation of $90M by 2028, a modest 1.5x return on the current estimated valuation.

Bear (20%)-70%

Larger incumbents like Microsoft or Oracle, or well-funded competitors, develop more specialized public health solutions or aggressively target Zenysis's customer base. Slowed adoption rates, increased competition, or regulatory hurdles lead to stagnant growth and a down round, resulting in a valuation of $18M. Given the severe preference stack of $22.4M, common stock holders would likely receive little to no return.

Est. time to liquidity~4.5 years

Preference Stack Risk

severe

Investors hold $22.4M in liquidation preferences, which is 37.3% of the estimated $60M current valuation.

Dilution Risk

moderate

As a Series B company, Zenysis will likely require 1-2 more funding rounds before a potential exit, leading to further dilution for current equity holders.

Secondary Liquidity

none

Given its stage and private nature, there is currently no active secondary market for Zenysis equity.

Other — 2 roles

  • Careers
  • Open Positions · Partnering with governments to solve some of their hardest problems requires strong, multidisciplinary teams and high-quality coordination across diverse domains. 
View all 2 open roles at Zenysis →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Zenysis's data — designed to show you've done your homework.

  • 1

    “Given the 'Digital Public Good' status of Harmony, how does Zenysis plan to monetize its platform effectively while maintaining its open-source ethos and mission to serve public health?”

  • 2

    “With the goal to 'triple our global footprint over the next two years' and a team of 16 employees, what is the strategy for scaling operations, partnerships, and customer support efficiently across diverse geographies?”

  • 3

    “Considering the $22.4M in total funding and the Series B stage, what is the company's anticipated timeline and strategy for a liquidity event, and how is employee equity structured to ensure meaningful returns for common stock holders?”

Community

Valuation Sentiment

Our model estimates -54% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.